TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17556901

Group type: EXPERIMENTAL
Intervention: Esomeprazole (20 or 40 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Omeprazole (20 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Omeprazole (10 or 20 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ranitidine (300 mg)
Number of subjects: 0
Study: 15043959

Group type: EXPERIMENTAL
Intervention: Nicotinamide (1.2 g/m2)
Number of subjects: 552

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 552
Study: 11964587

Group type: EXPERIMENTAL
Intervention: nCPAP
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (Oxygen mask)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: nCPAP (air breathing)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (Oxygen mask, air breathing)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Oxygen therapy
Number of subjects: 34
Study: 10184835

Group type: EXPERIMENTAL
Intervention: Sertraline (50 to 150 mg/day)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Fluoxetine (20 to 60 mg/day)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 231
Study: 7897712

Group type: EXPERIMENTAL
Intervention: Site change every 48 hours of the CVC
Number of subjects: 42

Group type: COMPARATOR
Intervention: Wire guide exchange of the CVC every 48 hours at the same site
Number of subjects: 42
Study: 2523321

Group type: EXPERIMENTAL
Intervention: Gestrinone 2.5 mg twice weekly (increased to 2.5 mg three times a week if amenorrhea not achieved)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Danazol 600 mg/day (increased to 800 mg/day if amenorrhea not achieved)
Number of subjects: 39
Study: 869121

Group type: EXPERIMENTAL
Intervention: Soft dressing
Number of subjects: 51

Group type: COMPARATOR
Intervention: Plaster dressing
Number of subjects: 51
Study: 31892920

Group type: COMPARATOR
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Guided Self-Change (GSC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of GSC and NRT
Number of subjects: 60
Study: 28727541

Group type: EXPERIMENTAL
Intervention: High Health Burden subgroup
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Light Smokers subgroup
Number of subjects: 397

Group type: COMPARATOR
Intervention: Heavy Smoking Drinking Depressed subgroup
Number of subjects: 397
Study: 26256429

Group type: EXPERIMENTAL
Intervention: Levomilnacipran ER 40 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levomilnacipran ER 80 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levomilnacipran ER 120 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levomilnacipran ER (25-100 mg single dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levomilnacipran ER (25-300 mg multiple doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levomilnacipran ER (40, 80, 120 mg daily for 8 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: In vitro NE and 5-HT transporter inhibition
Number of subjects: 0
Study: 23439629

Group type: EXPERIMENTAL
Intervention: De qi acupuncture (needles manipulated until de qi was reached)
Number of subjects: 338

Group type: COMPARATOR
Intervention: Control acupuncture (needles inserted without manipulation)
Number of subjects: 338
Study: 19998046

Group type: EXPERIMENTAL
Intervention: 1% sucralfate lotion
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Spectrophotometric evaluation
Number of subjects: 21

Group type: COMPARATOR
Intervention: RTOG acute toxicity scale
Number of subjects: 21
Study: 19379610

Group type: EXPERIMENTAL
Intervention: CT-based staging
Number of subjects: 89
Study: 17378519

Group type: EXPERIMENTAL
Intervention: Self-care program (10-month duration)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard checkups
Number of subjects: 97
Study: 15722782

Group type: EXPERIMENTAL
Intervention: Drug therapy (e.g., anticonvulsants, lidocaine patch 5%, antidepressants, opioids, tramadol)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interventional treatments (e.g., peripheral or neuraxial nerve blockade, implanted spinal cord stimulators, implanted intrathecal catheters)
Number of subjects: 0
Study: 12482209

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg/day for migraine prophylaxis
Number of subjects: 119

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Migraine without aura (before treatment)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Migraine with aura (before treatment)
Number of subjects: 119
Study: 9463745

Group type: EXPERIMENTAL
Intervention: Pleural fluid pseudouridine concentrations in malignant group
Number of subjects: 77

Group type: COMPARATOR
Intervention: Pleural fluid pseudouridine concentrations in non-malignant group
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: ROC curve analysis
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Pleural fluid pseudouridine concentration > 65 mumol/L
Number of subjects: 77
Study: 7664723

Group type: EXPERIMENTAL
Intervention: 3 mg/d of acetylsalicylic acid
Number of subjects: 10
Study: 2764127

Group type: EXPERIMENTAL
Intervention: Naftidrofuryl, 600 mg
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 94

Group type: COMPARATOR
Intervention: Healthy subjects (group 1)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Intermittent claudications (group 2)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Rest pain (group 3)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Severe ischemic skin changes (group 4)
Number of subjects: 94
Study: 1097036

Group type: EXPERIMENTAL
Intervention: Wheat bran
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sugar cane residue (bagasse)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (normal diet without fibre supplements)
Number of subjects: 0
Study: 31492552

Group type: EXPERIMENTAL
Intervention: Motherwort injection (MI)
Number of subjects: 408

Group type: COMPARATOR
Intervention: No-treatment group
Number of subjects: 408
Study: 30972997

Group type: EXPERIMENTAL
Intervention: Rehabilitative aerobic exercise (3 months treadmill training)
Number of subjects: 90
Study: 29060810

Group type: EXPERIMENTAL
Intervention: NFB group (real-time fMRI neurofeedback)
Number of subjects: 41

Group type: COMPARATOR
Intervention: CTRL group (sham feedback)
Number of subjects: 41
Study: 25620016

Group type: EXPERIMENTAL
Intervention: Arteriovenous coupler therapy
Number of subjects: 195

Group type: COMPARATOR
Intervention: Normal care (control)
Number of subjects: 195
Study: 23572165

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 21799455

Group type: EXPERIMENTAL
Intervention: SoundBite Hearing System (intraoral bone conduction device)
Number of subjects: 22
Study: 19663196

Group type: EXPERIMENTAL
Intervention: omeprasol 20 mg twice a day + BTD 240 mg twice a day
Number of subjects: 50

Group type: COMPARATOR
Intervention: omeprasol 20 mg twice a day
Number of subjects: 50
Study: 14976272

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Guided Support Groups (SG)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Natural Course (NC)
Number of subjects: 171
Study: 10024613

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (7.8 mg daily)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Overall (all groups)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Infants (overall)
Number of subjects: 220
Study: 7675298

Group type: EXPERIMENTAL
Intervention: Intravenous injections of methylcobalamin (MB12)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Intravenous saline injections (placebo trial)
Number of subjects: 5
Study: 2254759

Group type: EXPERIMENTAL
Intervention: Continuous i.v. infusion of recombinant human granulocyte-macrophage colony-stimulating factor
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of recombinant human granulocyte-macrophage colony-stimulating factor
Number of subjects: 61
Study: 7307238

Group type: EXPERIMENTAL
Intervention: Sensory-motor education programme provided by an occupational therapist during prenatal classes.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study: 30766533

Group type: EXPERIMENTAL
Intervention: IL-1β blocker anakinra
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28188670

Group type: EXPERIMENTAL
Intervention: PPV/CPA (100 mg/day for 7 days before vaccination)
Number of subjects: 49

Group type: COMPARATOR
Intervention: PPV alone
Number of subjects: 49
Study: 25995280

Group type: EXPERIMENTAL
Intervention: Food, Activity, and Breastfeeding intervention (FAB) and Combination intervention (Combo)
Number of subjects: 802

Group type: COMPARATOR
Intervention: Usual care (control group) and Infant Sleep education intervention (Sleep)
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: FAB and Combo groups combined
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 802
Study: 24975855

Group type: EXPERIMENTAL
Intervention: Venous angioplasty
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 29
Study: 21116121

Group type: EXPERIMENTAL
Intervention: Application of absorbing materials for skin decontamination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional washing procedure
Number of subjects: 0
Study: 20532103

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg/kg, maximum dose 12 mg)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 62
Study: 17519312

Group type: EXPERIMENTAL
Intervention: Metformin (1700 mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study: 15303787

Group type: EXPERIMENTAL
Intervention: Sulfur (used alone or in combination with sodium sulfacetamide or salicylic acid)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topically applied sulfur
Number of subjects: 0
Study: 11435049

Group type: EXPERIMENTAL
Intervention: Lightwand technique (LW group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Laryngoscope (LS group)
Number of subjects: 60
Study: 10052663

Group type: EXPERIMENTAL
Intervention: Atropine (0.04 mg x kg(‐1))
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Propranolol (0.2 mg x kg(‐1))
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Propranolol plus Atropine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Atropine and Propranolol plus Atropine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Partial and double blockade during exercise
Number of subjects: 6
Study: 7982351

Group type: EXPERIMENTAL
Intervention: Novel words interpreted as proper names
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel words interpreted as adjectives/mass nouns
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel words for non-pet animals not described as possessed
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel words for simple or complex artifacts
Number of subjects: 0
Study: 29307087

Group type: EXPERIMENTAL
Intervention: Selexipag
Number of subjects: 376

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 376
Study: 27046670

Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 63
Study: 26580866

Group type: EXPERIMENTAL
Intervention: Fractional ablative Er:YAG 2940-nm laser (FELR) with topical anti-aging and anti-pigment agents followed by ultrasound treatment
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment following FELR and topical agents
Number of subjects: 15

Group type: COMPARATOR
Intervention: FELR and topical agents alone
Number of subjects: 15
Study: 23700011

Group type: EXPERIMENTAL
Intervention: 9‐cis β‐carotene (300 mg daily for 90 days)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (starch, daily for 90 days)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 9‐cis β‐carotene
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 20502135

Group type: EXPERIMENTAL
Intervention: Valproate (VPA)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Multidrug therapy
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Combination of VPA-LEV
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Antiepileptic drugs (AEDs) for the first 2 months
Number of subjects: 98

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 98
Study: 19509119

Group type: EXPERIMENTAL
Intervention: Communities That Care (CTC) intervention
Number of subjects: 4407

Group type: COMPARATOR
Intervention: Control communities
Number of subjects: 4407
Study: 17184146

Group type: EXPERIMENTAL
Intervention: Fenofibrate treatment for three months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (n=10)
Number of subjects: 10
Study: 15058374

Group type: EXPERIMENTAL
Intervention: 0.05% chlorhexidine mouth rinse (test group)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo mouth rinse (control group)
Number of subjects: 33
Study: 11317112

Group type: EXPERIMENTAL
Intervention: Active physiotherapy
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Muscle reconditioning on devices
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Low-impact aerobics
Number of subjects: 148
Study: 9135178

Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia with bupivacaine 0.5% followed by bupivacaine 0.375% infusion
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standardised general anaesthetic (control group)
Number of subjects: 16
Study: 8188889

Group type: EXPERIMENTAL
Intervention: Retinoic acid
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vehicle (inactive)
Number of subjects: 60
Study: 2472262

Group type: EXPERIMENTAL
Intervention: Insulin (0.2 U/kg b.w.) with pentagastrin (2 micrograms/kg b.w.)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Pentagastrin infusion (control)
Number of subjects: 6
Study: 29406294

Group type: EXPERIMENTAL
Intervention: Interventions applied during early healing stages after hemorrhoidectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interventions applied in postburn hypertrophic scarring with contracture
Number of subjects: 0
Study: 27697876

Group type: EXPERIMENTAL
Intervention: ReTrain (25 sessions)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (exercise advice booklet)
Number of subjects: 48
Study: 25683660

Group type: EXPERIMENTAL
Intervention: Supplementation of vitamin D (cholecalciferol) in dosages depending upon 25(OH)‐D levels
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (nonintervention)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Supplementation of vitamin D (cholecalciferol)
Number of subjects: 180
Study: 23442556

Group type: EXPERIMENTAL
Intervention: tele‐based MBCT intervention
Number of subjects: 190

Group type: COMPARATOR
Intervention: patient education
Number of subjects: 190
Study: 20184043

Group type: EXPERIMENTAL
Intervention: Jasmine oil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 19767147

Group type: EXPERIMENTAL
Intervention: Amethocaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 15764759

Group type: EXPERIMENTAL
Intervention: CPAP treatment
Number of subjects: 26

Group type: COMPARATOR
Intervention: Oxygen therapy
Number of subjects: 26
Study: 12665489

Group type: EXPERIMENTAL
Intervention: Statin pretreatment
Number of subjects: 1552

Group type: EXPERIMENTAL
Intervention: Statin pretreatment in patients with hsCRP > or =1.11 mg/dL
Number of subjects: 1552

Group type: COMPARATOR
Intervention: No statin therapy
Number of subjects: 1552

Group type: EXPERIMENTAL
Intervention: Statin pretreatment in highest hsCRP quartile
Number of subjects: 1552
Study: 10388979

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion (2.4 pmol.kg‐1.min‐1)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 6
Study: 8777100

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 1891606

Group type: EXPERIMENTAL
Intervention: Topical anesthetic
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical placebo
Number of subjects: 0
Study: 6646145

Group type: EXPERIMENTAL
Intervention: Special formula (HN 25) with low lactose content (1.8%) or virtually free of lactose (0.05%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Partially adapted formula
Number of subjects: 0
Study: 31113407

Group type: EXPERIMENTAL
Intervention: Antenatal care (ANC) visits
Number of subjects: 789

Group type: EXPERIMENTAL
Intervention: Institutional delivery
Number of subjects: 789

Group type: EXPERIMENTAL
Intervention: Postnatal care (PNC)
Number of subjects: 789

Group type: EXPERIMENTAL
Intervention: ANC attendance associated factors
Number of subjects: 789

Group type: EXPERIMENTAL
Intervention: Birth in health facilities associated factors
Number of subjects: 789

Group type: EXPERIMENTAL
Intervention: PNC checkups
Number of subjects: 789
Study: 28355594

Group type: EXPERIMENTAL
Intervention: Non-technical skills seminar (NTS group, n=43)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Medical seminar (control group, n=34)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 77
Study: 26846253

Group type: EXPERIMENTAL
Intervention: Touch massage (TM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-active transcutaneous electrical nerve stimulation (non-TENS)
Number of subjects: 50
Study: 24170152

Group type: EXPERIMENTAL
Intervention: Pulse irrigation with 2 L normal saline (<15 psi)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Standard irrigation with 2 L normal saline poured into the wound
Number of subjects: 128
Study: 22451437

Group type: EXPERIMENTAL
Intervention: WHEY (25 g of whey protein)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: LEU (6.25 g whey protein with total leucine equivalent to WHEY)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: EAA-LEU (6.25 g whey protein with total essential amino acids equivalent to WHEY except leucine)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (FAST)
Number of subjects: 24
Study: 20050300

Group type: EXPERIMENTAL
Intervention: Electroacupuncture applied to acupuncture points PC6 and HT7 for 20 minutes twice a week for 8 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group continued rehabilitation without electroacupuncture
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group continued rehabilitation
Number of subjects: 33
Study: 16996224

Group type: EXPERIMENTAL
Intervention: Contingency Management (ContM) - only
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: MET+CBT+ContM
Number of subjects: 240

Group type: COMPARATOR
Intervention: MET+CBT
Number of subjects: 240

Group type: COMPARATOR
Intervention: Case-management control condition
Number of subjects: 240
Study: 14742374

Group type: EXPERIMENTAL
Intervention: Heat and moisture exchangers (HMEs)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: One type of HME
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Other HMEs
Number of subjects: 3
Study: 11286433

Group type: EXPERIMENTAL
Intervention: Low dose pergolide
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: High dose pergolide
Number of subjects: 255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study: 9451466

Group type: EXPERIMENTAL
Intervention: 5-month individualized progressive resistance training programme (moderate intensity, high volume) twice a week
Number of subjects: 38
Study: 7938786

Group type: EXPERIMENTAL
Intervention: Dynamic presentation procedure
Number of subjects: 16

Group type: COMPARATOR
Intervention: Static presentation procedure
Number of subjects: 16
Study: 2896359

Group type: EXPERIMENTAL
Intervention: Zuclopenthixol (4 mg daily, increased if necessary over 4 weeks)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Melperon (75 mg daily, increased if necessary over 4 weeks)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Both treatments (Zuclopenthixol and Melperon)
Number of subjects: 53
Study: 30928088

Group type: EXPERIMENTAL
Intervention: Intervention group with real time registry, navigator, and clinical feedback.
Number of subjects: 302

Group type: COMPARATOR
Intervention: Retrospective control group (Blacks 79.8% vs. Whites 87.3%, p < 0.001).
Number of subjects: 302

Group type: COMPARATOR
Intervention: Concurrent control group (Blacks 83.1% vs. Whites 90.1%, p < 0.001).
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Intervention group compared to retrospective control for Blacks.
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Intervention group compared to concurrent control for Blacks.
Number of subjects: 302
Study: 31277595

Group type: EXPERIMENTAL
Intervention: Ex-HMB (exercise intervention with HMB)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Ex-Plac (exercise intervention with placebo)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: NoEx-HMB (no exercise intervention with HMB)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Controls (No exercise and no HMB)
Number of subjects: 104
Study: 29137500

Group type: COMPARATOR
Intervention: Philani+ intervention using community health workers (Mentor Mothers) for pre- and postnatal home visits over twenty-four months.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Philani+ intervention
Number of subjects: 0
Study: 26738450

Group type: EXPERIMENTAL
Intervention: DLX105 (single-chain anti-TNF-α antibody)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical DLX105 (0.5% hydrogel formulation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical DLX105 with weekly tape stripping
Number of subjects: 0